Showing results (191-200 of 294) with videos related to
Sort By:
Pageof 30
Journal of Chemical Information and Modeling|May 30, 2019
Characterization of Hydration Properties in Structural Ensembles of BiomoleculesMohan R Pradhan, Minh N Nguyen, Srinivasaraghavan Kannan, et al.Journal of Molecular Biology|November 10, 2009
Rational design and biophysical characterization of thioredoxin-based aptamers: insights into peptide graftingChristopher J Brown, Shubhra Ghosh Dastidar, Hai Yun See, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2008
Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatinKelly A Avery-Kiejda, Xu Dong Zhang, Luke J Adams, et al.Cancer Research|June 17, 2005
Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1David E MacCallum, Jean Melville, Sheelagh Frame, et al.Cell Cycle (Georgetown, Tex.)|May 28, 2010
Detection of the 113p53 protein isoform: a p53-induced protein that feeds back on the p53 pathway to modulate the p53 response in zebrafishLin Guo, Joy Chua, Danesh Vijayakumar, et al.Cell Cycle (Georgetown, Tex.)|July 21, 2009
Ubiquitination of HEXIM1 by HDM2Joanne Lau, Qiao Jing Lew, Gaelle Diribarne, et al.Journal of Molecular Medicine (Berlin, Germany)|January 5, 2012
The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanismsLudovica Ciuffreda, Cristina Di Sanza, Ursula Cesta Incani, et al.Proceedings of the National Academy of Sciences of the United States of America|February 1, 2005
Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor designGeorge Kontopidis, Su-Ying Wu, Daniella I Zheleva, et al.Cancer Research|November 9, 2021
CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based TherapiesLong Jiang, Katrine Ingelshed, Yunbing Shen, et al.Cancer Research|May 30, 2019
Bortezomib Stabilizes and Activates p53 in Proliferative Compartments of Both Normal and Tumor Tissues In VivoYuezhen Xue, Nick Barker, Shawn Hoon, et al.Pageof 30